Atlas Trials

A Study of TAK-103 in Adult With Solid Tumors

Clinical trial NCT05164666 · TERMINATED

Trial details

NCT number
NCT05164666
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2022-01-05
Primary completion
2025-02-22
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.